Synapticure GTM brain

Synapticure provides virtual specialist neurology and coordinated support to people with neurodegenerative conditions and their caregivers across the United States.

category

Virtual neurodegenerative care

market profile

  • text: Patients with ALS, dementia and movement disorders need specialists, care coordination and caregiver support that may be difficult to access locally.
  • text: The company also partners with providers, health plans and accountable care organizations, including around the CMS GUIDE dementia model.

personas

  • title: Patient living with ALS, Parkinson's or dementia
    pains:
    • Specialist care can involve long waits and difficult travel
    • Needs a personalized plan and support coordinating multiple services
  • title: Family caregiver
    pains:
    • Coordinates appointments, symptoms and day-to-day care while managing emotional strain
    • Needs access to support and clear guidance
  • title: Health plan or health system clinical leader
    pains:
    • Specialist shortages leave members with fragmented neurological care
    • Needs a partner that can work alongside existing clinicians

icp

  • text: US patients and caregivers managing Alzheimer's, related dementia, ALS or movement disorders, especially when travel to specialists is difficult.
  • text: US health plans, provider groups and accountable care organizations serving neurodegenerative populations or participating in dementia care programs.

message pillars

  • text: Make specialist access easier through virtual visits.
  • text: Pair specialist care with a dedicated care team and individualized plan.
  • text: Coordinate with the patient's local doctors.
  • text: Provide broad geographic and insurance access.

objections

  • objection: Will this replace my local doctor?
    response: Explain how the virtual team collaborates with local clinicians and what still requires in-person care.
  • objection: Will insurance cover the visit?
    response: Check the patient's individual plan and expected cost before intake; coverage varies.
  • objection: Can virtual visits address complex neurological needs?
    response: Review the patient's clinical needs and explain the role of local services alongside the virtual care team.

competitors

  • name: Isaac Health
    why: Virtual memory and dementia specialist care and navigation.
  • name: Rippl Care
    why: Dementia care and caregiver support for overlapping patient populations.
  • name: Neura Health
    why: Virtual neurology care with overlapping specialist access needs.

keywords

  • virtual ALS specialist
  • telehealth dementia care
  • online Parkinson's neurologist
  • neurology care coordination
  • dementia caregiver support
  • CMS GUIDE dementia care

voice

  • empathetic and reassuring
  • clear and accessible
  • patient and caregiver centered

signals

  • text: A health system faces long waits for neurological specialists or gaps in dementia care coordination.
  • text: A provider or ACO is seeking a partner for the CMS GUIDE dementia model.
  • text: A caregiver is managing fragmented referrals and difficulty traveling to specialist visits.

pricing

model: unknown

motion

hybrid

channels

  • provider referrals
  • patient advocacy partnerships
  • SEO
  • health plan partnerships
  • press

confidence

high

Founders

  • name: Peter Wallach
    title: Founding CEO, Founder
    role: CEO
    bio: Founder / Founding CEO, SynaptiCure Inc. Eternal optimist. Recovering Bain consultant and avid baseball fan.
  • name: Brian Wallach
    title: Founder
    role: Founder
    bio: Brian Wallach is an attorney and ALS patient. In the aftermath of his diagnosis in November 2017, he and his wife founded I AM ALS, a patient-led, patient-centric movement to lead the fight for a cure to the disease. Wallach is also an associate at the law firm Skadden, Arps, Slate, Meagher & Flom LLP. From 2014 to 2018, he served as an assistant United States attorney in the Northern District of Illinois. From 2011 to 2013, he was senior vetting counsel in the Obama White House.
  • name: Martina de Majo
    title: Founder
    role: Founder
    bio: Martina is the director of research and development at Synapticure and she focuses on creating iPSC derived in vitro models to study neurodegenerative disorders. Martina received an undergraduate degree in biotechnology and a Master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza" (Italy), she then earned a PhD in clinical neuroscience from King's College London (UK) and deepened her knowledge of iPSC derived modelling in her postdoc at UCSF (US)

Back to YC companies